Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Vickers Selwyn M MD, Director. Director active across 1 company, notably Forma Therapeutics Holdings, Inc.. Aggregated, 2 filings have been logged. Activity tracked since 17 June 2021. The latest transaction was disclosed on 8 June 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Selwyn M. Vickers, MD, is a Director of Forma Therapeutics Holdings, Inc. In this role, he contributes to the governance of the company and strategic direction. Forma Therapeutics Holdings, Inc. is committed to developing innovative therapies to treat serious diseases. Selwyn brings valuable medical and strategic expertise to the leadership team.